Attention Investors
Kindly note the Change in PAY IN for BSE A/C No. : 1201250000000691 (CDSL), if you have an NSDL A/C, kindly use INTER DEPOSITORY SLIP. For assistance, please call OR contact: Mr. Dadu, 98339 89807 / 022-6145 1000.    |   Exchanges / Depository: Prevent Unauthorized Transactions in your Trading / Demat account --> Update your Mobile Numbers / email IDs with your Stock Brokers / Depository Participant. Receive alerts on your Registered Mobile / email IDs for trading account transactions and all debit and other important transactions in your demat account directly from Exchange / Depository on the same day ......................Issued in the interest of Investors."     |    KYC : "KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."     |    ASBA-IPO : "No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
 ««+1  ««-1
 
 
Akums Drugs & Pharmaceuticals LtdIndustry : Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code:544222NSE Symbol: AKUMSP/E(TTM):48.67
ISIN Demat:INE09XN01023Div & Yield %:0EPS(TTM):8.71
Book Value(Rs):150.8182636Market Cap ( Cr.):6671.93Face Value(Rs):2
    Change Company 
( In Cr)
 Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
INCOME :      
Sales Turnover 1311.781444.121286.831162.06837.44736.91
Excise Duty0.000.000.000.000.000.00
Net Sales1311.781444.121286.831162.06837.44736.91
Other Income 128.0694.1296.1558.4854.5165.52
Stock Adjustments 10.05-6.443.0618.45-10.64-8.52
Total Income1449.891531.801386.041238.99881.31793.91
EXPENDITURE :      
Raw Materials 811.06867.24791.21786.51513.05457.83
Power & Fuel Cost45.3642.4042.0436.2528.6433.74
Employee Cost 201.74175.28147.30136.37122.65123.70
Other Manufacturing Expenses 68.1862.6942.0462.6251.8924.08
Selling and Administration Expenses 23.2731.9022.3316.8213.8012.05
Miscellaneous Expenses 37.60404.21147.63503.99319.5637.06
Less: Pre-operative Expenses Capitalised0.000.000.000.000.000.00
Total Expenditure1187.201583.731192.541542.551049.59688.46
Operating Profit262.69-51.93193.50-303.56-168.28105.45
Interest 15.3118.3113.183.650.824.34
Gross Profit247.38-70.24180.32-307.21-169.10101.11
Depreciation39.5532.6930.0027.7626.1025.26
Profit Before Tax207.83-102.93150.32-334.97-195.2075.85
Tax46.8462.5241.000.346.4023.61
Fringe Benefit tax0.000.000.000.000.000.00
Deferred Tax0.000.00-16.1146.46-56.171.38
Reported Net Profit161.00-165.45125.43-381.78-145.4350.86
Extraordinary Items -0.04-7.98-105.110.99-255.750.02
Adjusted Net Profit161.04-157.47230.54-382.77110.3250.84
Adjst. below Net Profit 861.44-2.180.00-11.620.160.00
P & L Balance brought forward295.39463.02351.36744.75890.02839.52
Statutory Appropriations 0.000.000.000.000.000.00
Appropriations 0.000.0013.770.000.000.37
P & L Balance carried down1317.83295.39463.02351.36744.75890.02
Dividend0.000.000.000.000.000.00
Preference Dividend0.000.000.000.000.000.00
Equity Dividend %0.000.000.000.000.000.00
Earnings Per Share-Unit Curr10.52-11.568.77-53.37-1117.82391.04
Earnings Per Share(Adj)-Unit Curr10.52NANANANANA
Book Value-Unit Curr150.5710.0621.7725.944358.555476.91